Trials / Completed
CompletedNCT03141645
Comparison of IV Fluid Loading and Ondansetron in Reduction of PONV After LC
Comparison of Preoperative Intravenous Fluid Loading and Ondansetron in Reduction of Incidence Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- Siriraj Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to examine the incidence of postoperative nausea and vomiting during 24 hours after elective laparoscopic cholecystectomy in patients receiving preoperative intravenous fluid loading (group F), ondansetron (group O) and receiving neither fluid nor ondansetron or control group (group C).
Detailed description
This study is a prospective randomized control trial. It is designed to examine the incidence of postoperative nausea and vomiting during 24 hours after elective laparoscopic cholecystectomy in patients receiving preoperative intravenous fluid loading (group F), ondansetron (group O) and receiving neither fluid nor ondansetron or control group (group C). This study is hypothesized that the incidence of PONV in patients receiving preoperative intravenous fluid loading (group F) and patients receiving ondansetron (group O) will be similarly reduced from the control group (receiving neither fluid nor ondansetron).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fluid loading | Patients in the preoperative intravenous fluid loading group (group F) will receive ringer lactate solution 10ml/kg in 15 minutes before starting operation. |
| DRUG | Ondansetron | Patients in the ondansetron group (group O) will receive an 8 mg of intravenous ondansetron in 15 minutes before finishing operation |
Timeline
- Start date
- 2017-06-20
- Primary completion
- 2018-12-31
- Completion
- 2019-04-01
- First posted
- 2017-05-05
- Last updated
- 2019-04-04
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03141645. Inclusion in this directory is not an endorsement.